Earnings per share in the quarter was $0.66, which is up 65%.
This yields an adjusted earnings per share guidance range of $2.55 to $2.70, reflecting increased confidence in our ability to lift the bottom end of the range while still managing through inflation and supply chain challenges.
Earnings per share in the quarter was $0.66, which is up 65%.
For Xylem overall, we now see full year organic revenue growth in the range of 6 to 8%, up from our previous guidance range of 5 to 7%.
